Literature DB >> 12016238

Generalized anxiety and panic disorder.

Joseph Rabatin1, Lynn Buckvar Keltz.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12016238      PMCID： PMC1071705          DOI： 10.1136/ewjm.176.3.164

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  11 in total

1.  Panic disorder--it's real and it's treatable.

Authors:  R M Glass
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

2.  Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.

Authors:  M H Pittler; E Ernst
Journal:  J Clin Psychopharmacol       Date:  2000-02       Impact factor: 3.153

3.  Long-term buspirone therapy for chronic anxiety: a multicenter international study to determine safety.

Authors:  R E Rakel
Journal:  South Med J       Date:  1990-02       Impact factor: 0.954

4.  Lifetime panic-depression comorbidity in the National Comorbidity Survey.

Authors:  R C Kessler; P E Stang; H U Wittchen; T B Ustun; P P Roy-Burne; E E Walters
Journal:  Arch Gen Psychiatry       Date:  1998-09

5.  Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.

Authors:  Y Lecrubier; R Judge
Journal:  Acta Psychiatr Scand       Date:  1997-02       Impact factor: 6.392

6.  A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.

Authors:  Y Lecrubier; A Bakker; G Dunbar; R Judge
Journal:  Acta Psychiatr Scand       Date:  1997-02       Impact factor: 6.392

7.  Long-term pharmacological treatment of generalized anxiety disorder.

Authors:  V Mahe; A Balogh
Journal:  Int Clin Psychopharmacol       Date:  2000-03       Impact factor: 1.659

8.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

9.  Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies.

Authors:  R E Gammans; J C Stringfellow; A J Hvizdos; R J Seidehamel; J B Cohn; C S Wilcox; L F Fabre; J C Pecknold; W T Smith; K Rickels
Journal:  Neuropsychobiology       Date:  1992       Impact factor: 2.328

10.  Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo.

Authors:  J C Pecknold; M Matas; B G Howarth; C Ross; R Swinson; C Vezeau; W Ungar
Journal:  Can J Psychiatry       Date:  1989-11       Impact factor: 4.356
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.